Detalhe da pesquisa
1.
Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition.
J Exp Clin Cancer Res
; 43(1): 88, 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38515178
2.
Single-organoid analysis reveals clinically relevant treatment-resistant and invasive subclones in pancreatic cancer.
NPJ Precis Oncol
; 7(1): 128, 2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38066116